Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

Award Notice Posted

Solicitation number
75A50124C00046
Agency
Awarded
to Cerus Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
75A50124C00046 Federal contract award
Place of performance
Concord, California 94520, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) awarded Contract Number 75A50124C00046 to Cerus Corporation on September 23, 2024, for a value of $248,591,407.65. The contract is for licensing pathogen reduction technology (PRT) for red blood cell (RBC) components to reduce the risk of transfusion-transmitted infection, with the capability to treat over 10 million RBC components per year. The contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response.

Notice text

License pathogen reduction technology (PRT) for red blood cell (RBC) components to reduce the risk of transfusion-transmitted infection (TTI) by recognized emerging, epidemic, and endemic pathogens that is capable of treating over 10 million RBC components per year.

Awarded contract 75A50124C00046 to CERUS CORPORATION for 248591407.65 on 2024-09-23.

Files

File Type Posted
SAM Post Award Notification - 10.3.2024 (Cerus).pdf PDF

Notice history

5 of 13 notices listed here. See the rest on GovTribe.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity